CoChat
Sign Up
Cited by 678

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer

Han, Qing-Fang, Li, Wen-Jia, Hu, Kai-Shun, Gao, Jie, Zhai, Wen-Long, Yang, Jing-Hua, Zhang, Shui-Jun·2022·Molecular Cancer
DOI 10.1186/s12943-022-01671-0PMC PMC9623991
Open this paper in CoChat — free account

Abstract

Exosomes are well-known key mediators of intercellular communication and contribute to various physiological and pathological processes. Their biogenesis involves four key steps, including cargo sorting, MVB formation and maturation, transport of MVBs, and MVB fusion with the plasma membrane. Each process is modulated through the competition or coordination of multiple mechanisms, whereby diverse repertoires of molecular cargos are sorted into distinct subpopulations of exosomes, resulting in the high heterogeneity of exosomes. Intriguingly, cancer cells exploit various strategies, such as aberrant gene expression, posttranslational modifications, and altered signaling pathways, to regulate the biogenesis, composition, and eventually functions of exosomes to promote cancer progression. Therefore, exosome biogenesis-targeted therapy is being actively explored. In this review, we systematically summarize recent progress in understanding the machinery of exosome biogenesis and how it is regulated in the context of cancer. In particular, we highlight pharmacological targeting of exosome biogenesis as a promising cancer therapeutic strategy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-022-01671-0

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Overview of the process for exosome biogenesis. MVBs take the center of exosome biogenesis. Generally, MVBs are derived from endocytosis, during which different mechanisms mediate the inward budding of the plasma membrane and the formation of early endosomes. MVBs can dynamically communicate with other organelles or compartments including trans-Golgi network (TGN), endoplasmic reticulum (ER), mitochondrion, phagosome, RNA granule and micronuclei, et al. Therefore, different repertoires of cargos such as proteins, RNAs, DNAs or lipids are sorted into MVBs. After the maturation of MVBs, they can either fuse with lysosome to be degraded or fuse with plasma membrane to release ILVs, the so-called exosomes. Of note, MVB can fuse with autophagosome to form amphisome, which can either fuse with lysosome to be degraded or fuse with plasma membrane to secret exosomes
Fig. 1 Overview of the process for exosome biogenesis. MVBs take the center of exosome biogenesis. Generally, MVBs are derived from endocytosis, during which different mechanisms mediate the inward budding of the plasma membrane and the formation of early endosomes. MVBs can dynamically communicate with other organelles or compartments including trans-Golgi network (TGN), endoplasmic reticulum (ER), mitochondrion, phagosome, RNA granule and micronuclei, et al. Therefore, different repertoires of cargos such as proteins, RNAs, DNAs or lipids are sorted into MVBs. After the maturation of MVBs, they can either fuse with lysosome to be degraded or fuse with plasma membrane to release ILVs, the so-called exosomes. Of note, MVB can fuse with autophagosome to form amphisome, which can either fuse with lysosome to be degraded or fuse with plasma membrane to secret exosomesCC BY · PubMed Central
Fig. 2 Multiple mechanisms regulate the formation of ILVs. MVBs are characterized by containing intralumenal vesicles which can be controlled by multiple mechanisms. Generally, they can be divided into two categories which are ESCRT-dependent pathway and ESCRT-independent pathway. For the classical ESCRT-dependent pathways, ESCRT-0, -I, -II, -III subcomplexes and ATPase VPS4 cooperate in a stepwise manner to mediate the ILV formation (1). For the non-canonical ESCRT-dependent pathways, HD-PTP (2) or Alix (3) can both recognize specific cargos and recruit ESCRT-III and VPS4 to limiting membrane of MVBs, during which other ESCRT subcomplexes are not indispensable. In addition, several other proteins or pathways especially components of lipid rafts paly crucial roles in ESCRT-independent ILV formation. For example, CD63 could promote ILV formation by both ESCRT and ceramide-independent mechanism; nSMase2-ceramide pathway could drive ILV formation and MVB sorting of cargos such as PE-conjugated LC3 and its binding partners in an ESCRT-independent mechanism. Moreover, caveolin-1 or flotillins could drive lipid raft dependent ILV formation, during which process nSMase-ceramide pathway is required in some cell lines. Specially, F-actin formation on the limiting membrane of MVBs that was regulated by S1P signaling promotes ILV sorting of cargos, though the precise role of F-actin formation during the generation of ILVs is still elusive
Fig. 2 Multiple mechanisms regulate the formation of ILVs. MVBs are characterized by containing intralumenal vesicles which can be controlled by multiple mechanisms. Generally, they can be divided into two categories which are ESCRT-dependent pathway and ESCRT-independent pathway. For the classical ESCRT-dependent pathways, ESCRT-0, -I, -II, -III subcomplexes and ATPase VPS4 cooperate in a stepwise manner to mediate the ILV formation (1). For the non-canonical ESCRT-dependent pathways, HD-PTP (2) or Alix (3) can both recognize specific cargos and recruit ESCRT-III and VPS4 to limiting membrane of MVBs, during which other ESCRT subcomplexes are not indispensable. In addition, several other proteins or pathways especially components of lipid rafts paly crucial roles in ESCRT-independent ILV formation. For example, CD63 could promote ILV formation by both ESCRT and ceramide-independent mechanism; nSMase2-ceramide pathway could drive ILV formation and MVB sorting of cargos such as PE-conjugated LC3 and its binding partners in an ESCRT-independent mechanism. Moreover, caveolin-1 or flotillins could drive lipid raft dependent ILV formation, during which process nSMase-ceramide pathway is required in some cell lines. Specially, F-actin formation on the limiting membrane of MVBs that was regulated by S1P signaling promotes ILV sorting of cargos, though the precise role of F-actin formation during the generation of ILVs is still elusiveCC BY · PubMed Central
Fig. 3 Mechanisms mediating the transport and fate of MVBs. After the maturation of MVBs, they can either fuse with lysosome or fuse with plasma membrane. The activity of Rab7 plays a pivotal role for the fate of MVBs. Mon1a/b and neddylated Coro1a can activate Rab7 and promote dynein-dependent retrograde transport of MVBs towards the minus-end or perinuclear region. On the other hand, Arl8b/SKIP/HOPS/ TBC1D15 cascade or Rab31/TBC1D2B cascade could inactivate RAB7 and promote kinesin dependent antegrade transport of MVBs towards the plus-end or cell periphery. The antegrade transport of MVBs and their docking, tethering and fusion with plasma membrane are controlled by multiple factors including both proteins and lncRNAs. Notably, after the formation of MVBs, the ILVs inside can still retrofuse with the limiting membrane of MVBs and these ILVs are referred as retrofusing ILVs (rILVs). The others are recognized as secretory ILVs (sILVs) or degradative ILVs (dILVs)
Fig. 3 Mechanisms mediating the transport and fate of MVBs. After the maturation of MVBs, they can either fuse with lysosome or fuse with plasma membrane. The activity of Rab7 plays a pivotal role for the fate of MVBs. Mon1a/b and neddylated Coro1a can activate Rab7 and promote dynein-dependent retrograde transport of MVBs towards the minus-end or perinuclear region. On the other hand, Arl8b/SKIP/HOPS/ TBC1D15 cascade or Rab31/TBC1D2B cascade could inactivate RAB7 and promote kinesin dependent antegrade transport of MVBs towards the plus-end or cell periphery. The antegrade transport of MVBs and their docking, tethering and fusion with plasma membrane are controlled by multiple factors including both proteins and lncRNAs. Notably, after the formation of MVBs, the ILVs inside can still retrofuse with the limiting membrane of MVBs and these ILVs are referred as retrofusing ILVs (rILVs). The others are recognized as secretory ILVs (sILVs) or degradative ILVs (dILVs)CC BY · PubMed Central
Fig. 4 Proposed model showing the relationship between MVB secretion, actin reorganization and invadopodia formation. These three processes are highly organized and interrelated. Specifically, invadopodia determines the docking and secretion sites of MVBs on the plasma membrane. On the other hand, the fusion of MVBs on the plasma membrane contributes to the formation of invadopodia. And, F-actin formation is vital for both MVB secretion and invadopodia formation. Mechanistically, Rab27a and Rab35 seem to function at the center, the activity of which is regulated by their GAPs or GEFs. Particularly, Rab27a promotes both MVB docking and F-actin formation. Munc13-4 and Slp4 are effectors of Rab27a and function to mediate the docking and fusion of MVBs on the plasma membrane by promoting the formation of SNARE. Concurrently, Rab27a inhibits Coronin1b binding to invadopodia-associated actin and stabilizes Cortactin-mediated branched actin. In addition, actin-binding protein Fascin-1 is an effector of Rab35 and contributes to both invadopodia and exosome secretion. Moreover, exocyst complex binds to WASH, through which to promote Arp2/3 mediated actin polymerization and invadopodia formation. Also, exocyst binds to SNARE and mediates docking and fusion of MVBs on the plasma membrane
Fig. 4 Proposed model showing the relationship between MVB secretion, actin reorganization and invadopodia formation. These three processes are highly organized and interrelated. Specifically, invadopodia determines the docking and secretion sites of MVBs on the plasma membrane. On the other hand, the fusion of MVBs on the plasma membrane contributes to the formation of invadopodia. And, F-actin formation is vital for both MVB secretion and invadopodia formation. Mechanistically, Rab27a and Rab35 seem to function at the center, the activity of which is regulated by their GAPs or GEFs. Particularly, Rab27a promotes both MVB docking and F-actin formation. Munc13-4 and Slp4 are effectors of Rab27a and function to mediate the docking and fusion of MVBs on the plasma membrane by promoting the formation of SNARE. Concurrently, Rab27a inhibits Coronin1b binding to invadopodia-associated actin and stabilizes Cortactin-mediated branched actin. In addition, actin-binding protein Fascin-1 is an effector of Rab35 and contributes to both invadopodia and exosome secretion. Moreover, exocyst complex binds to WASH, through which to promote Arp2/3 mediated actin polymerization and invadopodia formation. Also, exocyst binds to SNARE and mediates docking and fusion of MVBs on the plasma membraneCC BY · PubMed Central
Fig. 5 Categories of mechanisms mediating the dysregulation of exosome biogenesis in cancer
Fig. 5 Categories of mechanisms mediating the dysregulation of exosome biogenesis in cancerCC BY · PubMed Central
Fig. 6 Aberrant activation of signaling pathways regulates exosome secretion in cancer. A. Increased Ca2+ in the cytosol that was caused by various stimuli contributes to the activity and function of multiple proteins mediating exosome generation, such as ESCRT, Alix-LBPA interaction, nSMase2, Munc13-4, and Syt7. B. RAS/RAF/MEK/ERK pathway signaling promotes the transcription of hnRNP H1, through which to facilitate exosome biogenesis by upregulating the expression of Alix and Rab27a. Moreover, there is a positive feedback loop between Ras signaling and hnRNP H1. In addition, ERK interacts with and phosphorylates Hrs, thereby promoting exosome secretion. C. Glutamine importer ASCT2 transfers extracellular glutamine (Gln) into the cell, where it can be converted into glutamate (Glu). Subsequently, intracellular glutamate is exported outside the cell by xCT. After binding to its receptor GRM3, GRM3 promotes Rab27-dependent exosome release. D. Activation of STAT3 promotes sequential phosphorylation of PKM2 and SNAP23, thereby accelerating the formation of the SNARE complex and exosome secretion
Fig. 6 Aberrant activation of signaling pathways regulates exosome secretion in cancer. A. Increased Ca2+ in the cytosol that was caused by various stimuli contributes to the activity and function of multiple proteins mediating exosome generation, such as ESCRT, Alix-LBPA interaction, nSMase2, Munc13-4, and Syt7. B. RAS/RAF/MEK/ERK pathway signaling promotes the transcription of hnRNP H1, through which to facilitate exosome biogenesis by upregulating the expression of Alix and Rab27a. Moreover, there is a positive feedback loop between Ras signaling and hnRNP H1. In addition, ERK interacts with and phosphorylates Hrs, thereby promoting exosome secretion. C. Glutamine importer ASCT2 transfers extracellular glutamine (Gln) into the cell, where it can be converted into glutamate (Glu). Subsequently, intracellular glutamate is exported outside the cell by xCT. After binding to its receptor GRM3, GRM3 promotes Rab27-dependent exosome release. D. Activation of STAT3 promotes sequential phosphorylation of PKM2 and SNAP23, thereby accelerating the formation of the SNARE complex and exosome secretionCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 236

  1. Crescitelli R, Lasser C, Lotvall J. Isolation and characterization of extracellular vesicle subpopulations from tissues. Nat Protoc. 2021;16(3):1548–80. · DOI
  2. Harding C. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol. 1983;97(2):329–39. · DOI · Paper page
  3. Hu W, Liu C, Bi Z-Y, Zhou Q, Zhang H, Li L-L, et al. Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology. Molecular Cancer. 2020;19(1):102. · DOI
  4. Marar C, Starich B, Wirtz D. Extracellular vesicles in immunomodulation and tumor progression. Nat Immunol. 2021;22(5):560–70. · DOI
  5. Yang E, Wang X, Gong Z, Yu M, Wu H, Zhang D. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduction and Targeted Therapy. 2020;5(1):242. · DOI
  6. Rezaie J, Ahmadi M, Ravanbakhsh R, Mojarad B, Mahbubfam S, Shaban SA, et al. Tumor-derived extracellular vesicles: The metastatic organotropism drivers. Life Sci. 2022;289:120216. · DOI
  7. Vahabi A, Rezaie J, Hassanpour M, Panahi Y, Nemati M, Rasmi Y, et al. Tumor Cells-derived exosomal CircRNAs: Novel cancer drivers, molecular mechanisms, and clinical opportunities. Biochem Pharmacol. 2022;200:115038. · DOI
  8. Di Mattia T, Tomasetto C, Alpy F. Faraway, so close! Functions of Endoplasmic reticulum-Endosome contacts. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(1):158490. · DOI
  9. Kwon SH, Oh S, Nacke M, Mostov KE, Lipschutz JH. Adaptor Protein CD2AP and L-type Lectin LMAN2 Regulate Exosome Cargo Protein Trafficking through the Golgi Complex. J Biol Chem. 2016;291(49):25462–75. · DOI
  10. Rabas N, Palmer S, Mitchell L, Ismail S, Gohlke A, Riley JS, et al. PINK1 drives production of mtDNA-containing extracellular vesicles to promote invasiveness. J Cell Biol. 2021;220(12):e202006049. · DOI
  11. Zhao YG, Codogno P, Zhang H. Machinery, regulation and pathophysiological implications of autophagosome maturation. Nat Rev Mol Cell Biol. 2021;22(11):733–50. · DOI
  12. Hurley JH, Boura E, Carlson LA, Rozycki B. Membrane budding. Cell. 2010;143(6):875–87. · DOI
  13. Schoneberg J, Lee IH, Iwasa JH, Hurley JH. Reverse-topology membrane scission by the ESCRT proteins. Nat Rev Mol Cell Biol. 2017;18(1):5–17. · DOI
  14. Pfitzner AK, Mercier V, Jiang X, Moser von Filseck J, Baum B, Saric A, et al. An ESCRT-III Polymerization Sequence Drives Membrane Deformation and Fission. Cell. 2020;182(5):1140–55 e1118. · DOI
  15. Huebner AR, Cheng L, Somparn P, Knepper MA, Fenton RA, Pisitkun T. Deubiquitylation of Protein Cargo Is Not an Essential Step in Exosome Formation. Molecular & cellular proteomics : MCP. 2016;15(5):1556–71. · DOI
  16. Kim SB, Kim HR, Park MC, Cho S, Goughnour PC, Han D, et al. Caspase-8 controls the secretion of inflammatory lysyl-tRNA synthetase in exosomes from cancer cells. J Cell Biol. 2017;216(7):2201–16. · DOI
  17. Majer O, Liu B, Kreuk LSM, Krogan N, Barton GM. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019;575(7782):366–70. · DOI
  18. Roucourt B, Meeussen S, Bao J, Zimmermann P, David G. Heparanase activates the syndecan-syntenin-ALIX exosome pathway. Cell Res. 2015;25(4):412–28. · DOI
  19. Zhang Y, Li Y, Liu P, Gong D, Zhou H, Li W, et al. Phosphatase Shp2 regulates biogenesis of small extracellular vesicles by dephosphorylating Syntenin. J Extracell Vesicles. 2021;10(5):e12078. · DOI
  20. Hyenne V, Labouesse M, Goetz JG. The Small GTPase Ral orchestrates MVB biogenesis and exosome secretion. Small GTPases. 2018;9(6):445–51. · DOI
  21. Egea-Jimenez AL, Zimmermann P. Phospholipase D and phosphatidic acid in the biogenesis and cargo loading of extracellular vesicles. J Lipid Res. 2018;59(9):1554–60. · DOI
  22. Larios J, Mercier V, Roux A, Gruenberg J. ALIX- and ESCRT-III-dependent sorting of tetraspanins to exosomes. J Cell Biol. 2020;219(3):e201904113. · DOI · Paper page
  23. Dores MR, Grimsey NJ, Mendez F, Trejo J. ALIX Regulates the Ubiquitin-Independent Lysosomal Sorting of the P2Y1 Purinergic Receptor via a YPX3L Motif. PLoS ONE. 2016;11(6):e0157587. · DOI
  24. Kazan JM, Desrochers G, Martin CE, Jeong H, Kharitidi D, Apaja PM, et al. Endofin is required for HD-PTP and ESCRT-0 interdependent endosomal sorting of ubiquitinated transmembrane cargoes. iScience. 2021;24(11):103274. · DOI
  25. Wenzel EM, Schultz SW, Schink KO, Pedersen NM, Nahse V, Carlson A, et al. Concerted ESCRT and clathrin recruitment waves define the timing and morphology of intraluminal vesicle formation. Nat Commun. 2018;9(1):2932. · DOI
  26. Bänfer S, Schneider D, Dewes J, Strauss MT, Freibert SA, Heimerl T, et al. Molecular mechanism to recruit galectin-3 into multivesicular bodies for polarized exosomal secretion. Proc Natl Acad Sci U S A. 2018;115(19):E4396-e4405. · DOI
  27. Schuldner M, Dorsam B, Shatnyeva O, Reiners KS, Kubarenko A, Hansen HP, et al. Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53. Theranostics. 2019;9(21):6047–62. · DOI
  28. Han Q, Lv L, Wei J, Lei X, Lin H, Li G, et al. Vps4A mediates the localization and exosome release of beta-catenin to inhibit epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett. 2019;457:47–59. · DOI
  29. Skotland T, Hessvik NP, Sandvig K, Llorente A. Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. J Lipid Res. 2019;60(1):9–18. · DOI · Paper page
  30. Dawson G. Isolation of Lipid Rafts (Detergent-Resistant Microdomains) and Comparison to Extracellular Vesicles (Exosomes). Methods Mol Biol. 2021;2187:99–112. · DOI
  31. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319(5867):1244–7. · DOI
  32. Guo BB, Bellingham SA, Hill AF. The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes. J Biol Chem. 2015;290(6):3455–67. · DOI
  33. Singh R, Pochampally R, Watabe K, Lu Z, Mo YY. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol Cancer. 2014;13:256. · DOI
  34. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, et al. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell. 1996;86(6):937–47. · DOI
  35. Leidal AM, Huang HH, Marsh T, Solvik T, Zhang D, Ye J, et al. The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat Cell Biol. 2020;22(2):187–99. · DOI
  36. Gulbins E, Kolesnick R. Raft ceramide in molecular medicine. Oncogene. 2003;22(45):7070–7. · DOI
  37. Savio LEB, de Andrade Mello P, Santos S, de Sousa JC, Oliveira SDS, Minshall RD, et al. P2X7 receptor activation increases expression of caveolin-1 and formation of macrophage lipid rafts, thereby boosting CD39 activity. J Cell Sci. 2020;133(5):jcs237560. · DOI
  38. Parton RG, McMahon KA, Wu Y. Caveolae: Formation, dynamics, and function. Curr Opin Cell Biol. 2020;65:8–16. · DOI
  39. Hayer A, Stoeber M, Ritz D, Engel S, Meyer HH, Helenius A. Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J Cell Biol. 2010;191(3):615–29. · DOI
  40. Albacete-Albacete L, Navarro-Lerida I, Lopez JA, Martin-Padura I, Astudillo AM, Ferrarini A, et al. ECM deposition is driven by caveolin-1-dependent regulation of exosomal biogenesis and cargo sorting. J Cell Biol. 2020;219(11):e202006178. · DOI
  41. Robinson H, Ruelcke JE, Lewis A, Bond CS, Fox AH, Bharti V, et al. Caveolin-1-driven membrane remodelling regulates hnRNPK-mediated exosomal microRNA sorting in cancer. Clin Transl Med. 2021;11(4):e381. · DOI
  42. Phuyal S, Hessvik NP, Skotland T, Sandvig K, Llorente A. Regulation of exosome release by glycosphingolipids and flotillins. FEBS J. 2014;281(9):2214–27. · DOI
  43. Kwiatkowska K, Matveichuk OV, Fronk J, Ciesielska A. Flotillins: At the Intersection of Protein S-Palmitoylation and Lipid-Mediated Signaling. Int J Mol Sci. 2020;21(7):2283. · DOI
  44. de Gassart A, Geminard C, Fevrier B, Raposo G, Vidal M. Lipid raft-associated protein sorting in exosomes. Blood. 2003;102(13):4336–44. · DOI
  45. Okabayashi S, Kimura N. LGI3 interacts with flotillin-1 to mediate APP trafficking and exosome formation. NeuroReport. 2010;21(9):606–10. · DOI
  46. Wei D, Zhan W, Gao Y, Huang L, Gong R, Wang W, et al. RAB31 marks and controls an ESCRT-independent exosome pathway. Cell Res. 2021;31(2):157–77. · DOI
  47. Frick M, Bright NA, Riento K, Bray A, Merrified C, Nichols BJ. Coassembly of flotillins induces formation of membrane microdomains, membrane curvature, and vesicle budding. Curr Biol. 2007;17(13):1151–6. · DOI
  48. Ikonen E, Zhou X. Cholesterol transport between cellular membranes: A balancing act between interconnected lipid fluxes. Dev Cell. 2021;56(10):1430–6. · DOI
  49. Wilhelm LP, Wendling C, Vedie B, Kobayashi T, Chenard MP, Tomasetto C, et al. STARD3 mediates endoplasmic reticulum-to-endosome cholesterol transport at membrane contact sites. EMBO J. 2017;36(10):1412–33. · DOI
  50. Eden ER, Sanchez-Heras E, Tsapara A, Sobota A, Levine TP, Futter CE. Annexin A1 Tethers Membrane Contact Sites that Mediate ER to Endosome Cholesterol Transport. Dev Cell. 2016;37(5):473–83. · DOI
  51. Strauss K, Goebel C, Runz H, Mobius W, Weiss S, Feussner I, et al. Exosome secretion ameliorates lysosomal storage of cholesterol in Niemann-Pick type C disease. J Biol Chem. 2010;285(34):26279–88. · DOI
  52. Zhao Z, Zhong L, Li P, He K, Qiu C, Zhao L, et al. Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p. Exp Cell Res. 2020;387(1):111738. · DOI
  53. Abdullah M, Nakamura T, Ferdous T, Gao Y, Chen Y, Zou K, et al. Cholesterol Regulates Exosome Release in Cultured Astrocytes. Front Immunol. 2021;12:722581. · DOI
  54. Kummer D, Steinbacher T, Schwietzer MF, Tholmann S, Ebnet K. Tetraspanins: integrating cell surface receptors to functional microdomains in homeostasis and disease. Med Microbiol Immunol. 2020;209(4):397–405. · DOI
  55. van Niel G, Charrin S, Simoes S, Romao M, Rochin L, Saftig P, et al. The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis. Dev Cell. 2011;21(4):708–21. · DOI · Paper page
  56. Ma S, Mangala LS, Hu W, Bayaktar E, Yokoi A, Hu W, et al. CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance. Cell Rep. 2021;36(7):109549. · DOI
  57. Yokoi A, Villar-Prados A, Oliphint PA, Zhang J, Song X, De Hoff P, et al. Mechanisms of nuclear content loading to exosomes. Science advances. 2019;5(11):eaax8849. · DOI
  58. Yanatori I, Richardson DR, Dhekne HS, Toyokuni S, Kishi F. CD63 is regulated by iron via the IRE-IRP system and is important for ferritin secretion by extracellular vesicles. Blood. 2021;138(16):1490–503. · DOI · Paper page
  59. Guix FX, Sannerud R, Berditchevski F, Arranz AM, Horre K, Snellinx A, et al. Tetraspanin 6: a pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments. Mol Neurodegener. 2017;12(1):25. · DOI
  60. Ghossoub R, Chery M, Audebert S, Leblanc R, Egea-Jimenez AL, Lembo F, et al. Tetraspanin-6 negatively regulates exosome production. Proc Natl Acad Sci U S A. 2020;117(11):5913–22. · DOI
  61. Kajimoto T, Mohamed NNI, Badawy SMM, Matovelo SA, Hirase M, Nakamura S, et al. Involvement of Gbetagamma subunits of Gi protein coupled with S1P receptor on multivesicular endosomes in F-actin formation and cargo sorting into exosomes. J Biol Chem. 2018;293(1):245–53. · DOI
  62. Kajimoto T, Okada T, Miya S, Zhang L, Nakamura S. Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes. Nat Commun. 2013;4:2712. · DOI
  63. Ekström EJ, Bergenfelz C, von Bülow V, Serifler F, Carlemalm E, Jönsson G, et al. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Mol Cancer. 2014;13:88. · DOI · Paper page
  64. Chen G, Huang AC, Zhang W, Zhang G, Wu M, Xu W, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018;560(7718):382–6. · DOI · Paper page
  65. Poggio M, Hu T, Pai CC, Chu B, Belair CD, Chang A, et al. Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory. Cell. 2019;177(2):414–27 e413. · DOI · Paper page
  66. Edgar JR, Eden ER, Futter CE. Hrs- and CD63-dependent competing mechanisms make different sized endosomal intraluminal vesicles. Traffic. 2014;15(2):197–211. · DOI
  67. Ghossoub R, Lembo F, Rubio A, Gaillard CB, Bouchet J, Vitale N, et al. Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat Commun. 2014;5:3477. · DOI
  68. Haraszti RA, Didiot MC, Sapp E, Leszyk J, Shaffer SA, Rockwell HE, et al. High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles. 2016;5:32570. · DOI · Paper page
  69. Jia S, Zhang Q, Wang Y, Wang Y, Liu D, He Y, et al. PIWI-interacting RNA sequencing profiles in maternal plasma-derived exosomes reveal novel non-invasive prenatal biomarkers for the early diagnosis of nonsyndromic cleft lip and palate. EBioMedicine. 2021;65:103253. · DOI
  70. Zhang S, Wang C, Ma B, Xu M, Xu S, Liu J, et al. Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90alpha Secretion. Cell Rep. 2020;32(1):107879. · DOI
  71. Zhong L, Liao D, Li J, Liu W, Wang J, Zeng C, et al. Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes. Signal Transduction and Targeted Ther. 2021;6(1):59. · DOI
  72. Iavello A, Frech VS, Gai C, Deregibus MC, Quesenberry PJ, Camussi G. Role of Alix in miRNA packaging during extracellular vesicle biogenesis. Int J Mol Med. 2016;37(4):958–66. · DOI · Paper page
  73. Géminard C, De Gassart A, Blanc L, Vidal M. Degradation of AP2 during reticulocyte maturation enhances binding of hsc70 and Alix to a common site on TFR for sorting into exosomes. Traffic. 2004;5(3):181–93. · DOI
  74. Ferreira JV, da Rosa Soares A, Ramalho J, MáximoCarvalho C, Cardoso MH, Pintado P, et al. LAMP2A regulates the loading of proteins into exosomes. Science advances. 2022;8(12):eabm1140. · DOI
  75. Fabbiano F, Corsi J, Gurrieri E, Trevisan C, Notarangelo M, D’Agostino VG. RNA packaging into extracellular vesicles: An orchestra of RNA-binding proteins? J Extracell Vesicles. 2020;10(2):e12043. · DOI
  76. Wozniak AL, Adams A, King KE, Dunn W, Christenson LK, Hung WT, et al. The RNA binding protein FMR1 controls selective exosomal miRNA cargo loading during inflammation. J Cell Biol. 2020;219(10):e201912074. · DOI
  77. Groot M, Lee H. Sorting Mechanisms for MicroRNAs into Extracellular Vesicles and Their Associated Diseases. Cells. 2020;9(4):1044. · DOI · Paper page
  78. Hobor F, Dallmann A, Ball NJ, Cicchini C, Battistelli C, Ogrodowicz RW, et al. A cryptic RNA-binding domain mediates Syncrip recognition and exosomal partitioning of miRNA targets. Nat Commun. 2018;9(1):831. · DOI
  79. Teng Y, Ren Y, Hu X, Mu J, Samykutty A, Zhuang X, et al. MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression. Nat Commun. 2017;8:14448. · DOI · Paper page
  80. Chen C, Luo Y, He W, Zhao Y, Kong Y, Liu H, et al. Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. J Clin Invest. 2020;130(1):404–21. · DOI
  81. Chen C, Zheng H, Luo Y, Kong Y, An M, Li Y, et al. SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer. J Clin Invest. 2021;131(8):e146431. · DOI
  82. Pan Z, Zhao R, Li B, Qi Y, Qiu W, Guo Q, et al. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. Mol Cancer. 2022;21(1):16. · DOI
  83. Chen C, Yu H, Han F, Lai X, Ye K, Lei S, et al. Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness. Mol Cancer. 2022;21(1):46. · DOI
  84. Roden C, Gladfelter AS. RNA contributions to the form and function of biomolecular condensates. Nat Rev Mol Cell Biol. 2021;22(3):183–95. · DOI
  85. Markmiller S, Soltanieh S, Server KL, Mak R, Jin W, Fang MY, et al. Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules. Cell. 2018;172(3):590–604 e513. · DOI
  86. Ryan VH, Dignon GL, Zerze GH, Chabata CV, Silva R, Conicella AE, et al. Mechanistic View of hnRNPA2 Low-Complexity Domain Structure, Interactions, and Phase Separation Altered by Mutation and Arginine Methylation. Mol Cell. 2018;69(3):465-479.e467. · DOI
  87. Liu XM, Ma L, Schekman R. Selective sorting of microRNAs into exosomes by phase-separated YBX1 condensates. Elife. 2021;10:e71982. · DOI
  88. Wang R, Cao L, Thorne RF, Zhang XD, Li J, Shao F, et al. LncRNA GIRGL drives CAPRIN1-mediated phase separation to suppress glutaminase-1 translation under glutamine deprivation. Science advances. 2021;7(13):eabe5708. · DOI
  89. Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of Exosome Composition. Cell. 2019;177(2):428–45 e418. · DOI · Paper page
  90. Torralba D, Baixauli F, Villarroya-Beltri C, Fernandez-Delgado I, Latorre-Pellicer A, Acin-Perez R, et al. Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts. Nat Commun. 2018;9(1):2658. · DOI
  91. Hanson PI, Cashikar A. Multivesicular body morphogenesis. Annu Rev Cell Dev Biol. 2012;28:337–62. · DOI
  92. Savina A, Fader CM, Damiani MT, Colombo MI. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic. 2005;6(2):131–43. · DOI
  93. Messenger SW, Woo SS, Sun Z, Martin TFJ. A Ca2+-stimulated exosome release pathway in cancer cells is regulated by Munc13-4. J Cell Biol. 2018;217(8):2877–90. · DOI
  94. Fan SJ, Kroeger B, Marie PP, Bridges EM, Mason JD, McCormick K, et al. Glutamine deprivation alters the origin and function of cancer cell exosomes. EMBO J. 2020;39(16):e103009. · DOI · Paper page
  95. Arya SB, Chen S, Jordan-Javed F, Parent CA. Ceramide-rich microdomains facilitate nuclear envelope budding for non-conventional exosome formation. Nat Cell Biol. 2022;24(7):1019–28. · DOI
  96. Jongsma ML, Bakker J, Cabukusta B, Liv N, van Elsland D, Fermie J, et al. SKIP-HOPS recruits TBC1D15 for a Rab7-to-Arl8b identity switch to control late endosome transport. EMBO J. 2020;39(6):e102301. · DOI
  97. Fei X, Li Z, Yang D, Kong X, Lu X, Shen Y, et al. Neddylation of Coro1a determines the fate of multivesicular bodies and biogenesis of extracellular vesicles. J Extracell Vesicles. 2021;10(12):e12153. · DOI
  98. Villarroya-Beltri C, Baixauli F, Mittelbrunn M, Fernandez-Delgado I, Torralba D, Moreno-Gonzalo O, et al. ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. Nat Commun. 2016;7:13588. · DOI
  99. Pedersen NM, Wenzel EM, Wang L, Antoine S, Chavrier P, Stenmark H, et al. Protrudin-mediated ER-endosome contact sites promote MT1-MMP exocytosis and cell invasion. J Cell Biol. 2020;219(8):e202003063. · DOI
  100. Perrin P, Janssen L, Janssen H, van den Broek B, Voortman LM, van Elsland D, et al. Retrofusion of intralumenal MVB membranes parallels viral infection and coexists with exosome release. Curr Biol. 2021;31(17):3884–93 e3884. · DOI
  101. Borchers AC, Langemeyer L, Ungermann C. Who's in control? Principles of Rab GTPase activation in endolysosomal membrane trafficking and beyond. J Cell Biol. 2021;220(9):e202105120. · DOI · Paper page
  102. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19–30. · DOI
  103. Alnaas AA, Watson-Siriboe A, Tran S, Negussie M, Henderson JA, Osterberg JR, et al. Multivalent lipid targeting by the calcium-independent C2A domain of synaptotagmin-like protein 4/granuphilin. J Biol Chem. 2021;296:100159. · DOI
  104. Park JI, Song KH, Kang SM, Lee J, Cho SJ, Choi HK, et al. BHMPS Inhibits Breast Cancer Migration and Invasion by Disrupting Rab27a-Mediated EGFR and Fibronectin Secretion. Cancers. 2022;14(2):373. · DOI
  105. Boswell KL, James DJ, Esquibel JM, Bruinsma S, Shirakawa R, Horiuchi H, et al. Munc13-4 reconstitutes calcium-dependent SNARE-mediated membrane fusion. J Cell Biol. 2012;197(2):301–12. · DOI
  106. Woo SS, James DJ, Martin TF. Munc13-4 functions as a Ca2+ sensor for homotypic secretory granule fusion to generate endosomal exocytic vacuoles. Mol Biol Cell. 2017;28(6):792–808. · DOI
  107. He J, Johnson JL, Monfregola J, Ramadass M, Pestonjamasp K, Napolitano G, et al. Munc13-4 interacts with syntaxin 7 and regulates late endosomal maturation, endosomal signaling, and TLR9-initiated cellular responses. Mol Biol Cell. 2016;27(3):572–87. · DOI
  108. Zhang J, Zhang K, Qi L, Hu Q, Shen Z, Liu B, et al. DENN domain-containing protein FAM45A regulates the homeostasis of late/multivesicular endosomes. Biochim Biophys Acta Mol Cell Res. 2019;1866(5):916–29. · DOI · Paper page
  109. Imai A, Ishida M, Fukuda M, Nashida T, Shimomura H. MADD/DENN/Rab3GEP functions as a guanine nucleotide exchange factor for Rab27 during granule exocytosis of rat parotid acinar cells. Arch Biochem Biophys. 2013;536(1):31–7. · DOI
  110. Itoh T, Fukuda M. Identification of EPI64 as a GTPase-activating protein specific for Rab27A. J Biol Chem. 2006;281(42):31823–31. · DOI
  111. Song L, Tang S, Han X, Jiang Z, Dong L, Liu C, et al. KIBRA controls exosome secretion via inhibiting the proteasomal degradation of Rab27a. Nat Commun. 2019;10(1):1639. · DOI
  112. Chen J, Lin Z, Liu L, Zhang R, Geng Y, Fan M, et al. GOLM1 exacerbates CD8+ T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages. Signal Transduct Target Ther. 2021;6(1):397. · DOI
  113. Hsu C, Morohashi Y, Yoshimura S, Manrique-Hoyos N, Jung S, Lauterbach MA, et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol. 2010;189(2):223–32. · DOI
  114. Bai S, Hou W, Yao Y, Meng J, Wei Y, Hu F, et al. Exocyst controls exosome biogenesis via Rab11a. Mol Ther Nucleic Acids. 2022;27:535–46. · DOI
  115. Wu S, Luo M, To KKW, Zhang J, Su C, Zhang H, et al. Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer. Mol Cancer. 2021;20(1):17. · DOI
  116. Liu BHM, Tey SK, Mao X, Ma APY, Yeung CLS, Wong SWK, et al. TPI1-reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis. J Extracell Vesicles. 2021;10(10):e12135. · DOI
  117. Matsui T, Sakamaki Y, Nakashima S, Fukuda M. Rab39 and its effector UACA regulate basolateral exosome release from polarized epithelial cells. Cell Rep. 2022;39(9):110875. · DOI
  118. Yuyama K, Sun H, Mikami D, Mioka T, Mukai K, Igarashi Y. Lysosomal-associated transmembrane protein 4B regulates ceramide-induced exosome release. FASEB J. 2020;34(12):16022–33. · DOI
  119. Lauwers E, Wang YC, Gallardo R, Van der Kant R, Michiels E, Swerts J, et al. Hsp90 Mediates Membrane Deformation and Exosome Release. Mol Cell. 2018;71(5):689–702 e689. · DOI
  120. Raiborg C, Wenzel EM, Pedersen NM, Olsvik H, Schink KO, Schultz SW, et al. Repeated ER-endosome contacts promote endosome translocation and neurite outgrowth. Nature. 2015;520(7546):234–8. · DOI
  121. Eddy RJ, Weidmann MD, Sharma VP, Condeelis JS. Tumor Cell Invadopodia: Invasive Protrusions that Orchestrate Metastasis. Trends Cell Biol. 2017;27(8):595–607. · DOI
  122. Peng X, Li X, Yang S, Huang M, Wei S, Ma Y, et al. LINC00511 drives invasive behavior in hepatocellular carcinoma by regulating exosome secretion and invadopodia formation. J Exp Clin Cancer Res. 2021;40(1):183. · DOI
  123. Hoshino D, Kirkbride KC, Costello K, Clark ES, Sinha S, Grega-Larson N, et al. Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep. 2013;5(5):1159–68. · DOI
  124. Sinha S, Hoshino D, Hong NH, Kirkbride KC, Grega-Larson NE, Seiki M, et al. Cortactin promotes exosome secretion by controlling branched actin dynamics. J Cell Biol. 2016;214(2):197–213. · DOI
  125. Monteiro P, Rosse C, Castro-Castro A, Irondelle M, Lagoutte E, Paul-Gilloteaux P, et al. Endosomal WASH and exocyst complexes control exocytosis of MT1-MMP at invadopodia. J Cell Biol. 2013;203(6):1063–79. · DOI
  126. Marat AL, Ioannou MS, McPherson PS. Connecdenn 3/DENND1C binds actin linking Rab35 activation to the actin cytoskeleton. Mol Biol Cell. 2012;23(1):163–75. · DOI
  127. Beghein E, Devriese D, Van Hoey E, Gettemans J. Cortactin and fascin-1 regulate extracellular vesicle release by controlling endosomal trafficking or invadopodia formation and function. Sci Rep. 2018;8(1):15606. · DOI
  128. Yoon TY, Munson M. SNARE complex assembly and disassembly. Curr Biol. 2018;28(8):R397–401. · DOI
  129. Kou X, Xu X, Chen C, Sanmillan ML, Cai T, Zhou Y, et al. The Fas/Fap-1/Cav-1 complex regulates IL-1RA secretion in mesenchymal stem cells to accelerate wound healing. Science translational medicine. 2018;10(432):eaai8524. · DOI
  130. Yang L, Peng X, Li Y, Zhang X, Ma Y, Wu C, et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol Cancer. 2019;18(1):78. · DOI
  131. Williams KC, McNeilly RE, Coppolino MG. SNAP23, Syntaxin4, and vesicle-associated membrane protein 7 (VAMP7) mediate trafficking of membrane type 1-matrix metalloproteinase (MT1-MMP) during invadopodium formation and tumor cell invasion. Mol Biol Cell. 2014;25(13):2061–70. · DOI
  132. Peak TC, Panigrahi GK, Praharaj PP, Su Y, Shi L, Chyr J, et al. Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer. Mol Carcinog. 2020;59(1):62–72. · DOI
  133. Kumar R, Tang Q, Muller SA, Gao P, Mahlstedt D, Zampagni S, et al. Fibroblast Growth Factor 2-Mediated Regulation of Neuronal Exosome Release Depends on VAMP3/Cellubrevin in Hippocampal Neurons. Adv Sci (Weinh). 2020;7(6):1902372. · DOI
  134. Hyenne V, Apaydin A, Rodriguez D, Spiegelhalter C, Hoff-Yoessle S, Diem M, et al. RAL-1 controls multivesicular body biogenesis and exosome secretion. J Cell Biol. 2015;211(1):27–37. · DOI
  135. Cha DJ, Franklin JL, Dou Y, Liu Q, Higginbotham JN, Demory Beckler M, et al. KRAS-dependent sorting of miRNA to exosomes. Elife. 2015;4:e07197. · DOI
  136. Qian L, Yang X, Li S, Zhao H, Gao Y, Zhao S, et al. Reduced O-GlcNAcylation of SNAP-23 promotes cisplatin resistance by inducing exosome secretion in ovarian cancer. Cell Death Discov. 2021;7(1):112. · DOI
  137. Soraya H, Sani NA, Jabbari N, Rezaie J. Metformin Increases Exosome Biogenesis and Secretion in U87 MG Human Glioblastoma Cells: A Possible Mechanism of Therapeutic Resistance. Arch Med Res. 2021;52(2):151–62. · DOI
  138. Manteghi S, Gingras MC, Kharitidi D, Galarneau L, Marques M, Yan M, et al. Haploinsufficiency of the ESCRT Component HD-PTP Predisposes to Cancer. Cell Rep. 2016;15(9):1893–900. · DOI
  139. Martellucci S, Clementi L, Sabetta S, Mattei V, Botta L, Angelucci A. Src Family Kinases as Therapeutic Targets in Advanced Solid Tumors: What We Have Learned so Far. Cancers. 2020;12(6):1448. · DOI · Paper page
  140. Fares J, Kashyap R, Zimmermann P. Syntenin: Key player in cancer exosome biogenesis and uptake? Cell Adh Migr. 2017;11(2):124–6. · DOI
  141. Ghoroghi S, Mary B, Larnicol A, Asokan N, Klein A, Osmani N, et al. Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes. Elife. 2021;10:e61539. · DOI
  142. Imjeti NS, Menck K, Egea-Jimenez AL, Lecointre C, Lembo F, Bouguenina H, et al. Syntenin mediates SRC function in exosomal cell-to-cell communication. Proc Natl Acad Sci U S A. 2017;114(47):12495–500. · DOI
  143. Si J, Li W, Li X, Cao L, Chen Z, Jiang Z. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma. Cancer Sci. 2021;112(9):3491–506. · DOI
  144. Andrijes R, Hejmadi RK, Pugh M, Rajesh S, Novitskaya V, Ibrahim M, et al. Tetraspanin 6 is a regulator of carcinogenesis in colorectal cancer. Proc Natl Acad Sci USA. 2021;118(39):e2011411118. · DOI
  145. Gauthier-Rouviere C, Bodin S, Comunale F, Planchon D. Flotillin membrane domains in cancer. Cancer Metastasis Rev. 2020;39(2):361–74. · DOI
  146. Li C, Qin F, Wang W, Ni Y, Gao M, Guo M, et al. hnRNPA2B1-Mediated Extracellular Vesicles Sorting of miR-122–5p Potentially Promotes Lung Cancer Progression. Int J Mol Sci. 2021;22(23):12866. · DOI
  147. Datta A, Kim H, Lal M, McGee L, Johnson A, Moustafa AA, et al. Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells. Cancer Lett. 2017;408:73–81. · DOI
  148. Koh HM, Jang BG, Kim DC. Prognostic significance of Rab27 expression in solid cancer: a systematic review and meta-analysis. Sci Rep. 2020;10(1):14136. · DOI
  149. Dorayappan KDP, Wanner R, Wallbillich JJ, Saini U, Zingarelli R, Suarez AA, et al. Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins. Oncogene. 2018;37(28):3806–21. · DOI
  150. Alonso-Curbelo D, Riveiro-Falkenbach E, Perez-Guijarro E, Cifdaloz M, Karras P, Osterloh L, et al. RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway. Cancer Cell. 2014;26(1):61–76. · DOI
  151. Ristic B, Kopel J, Sherazi SAA, Gupta S, Sachdeva S, Bansal P, et al. Emerging Role of Fascin-1 in the Pathogenesis, Diagnosis, and Treatment of the Gastrointestinal Cancers. Cancers. 2021;13(11):2536. · DOI
  152. Meng Y, Wang L, Chen D, Chang Y, Zhang M, Xu JJ, et al. LAPTM4B: an oncogene in various solid tumors and its functions. Oncogene. 2016;35(50):6359–65. · DOI
  153. Certo M, Tsai CH, Pucino V, Ho PC, Mauro C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol. 2021;21(3):151–61. · DOI · Paper page
  154. Sun H, Meng Q, Shi C, Yang H, Li X, Wu S, et al. Hypoxia-Inducible Exosomes Facilitate Liver-Tropic Premetastatic Niche in Colorectal Cancer. Hepatology. 2021;74(5):2633–51. · DOI
  155. Jafari R, Rahbarghazi R, Ahmadi M, Hassanpour M, Rezaie J. Hypoxic exosomes orchestrate tumorigenesis: molecular mechanisms and therapeutic implications. J Transl Med. 2020;18(1):474. · DOI
  156. Xi L, Peng M, Liu S, Liu Y, Wan X, Hou Y, et al. Hypoxia-stimulated ATM activation regulates autophagy-associated exosome release from cancer-associated fibroblasts to promote cancer cell invasion. J Extracell Vesicles. 2021;10(11):e12146. · DOI
  157. Muniz-Garcia A, Romero M, Falcomicronn-Perez JM, Murray P, Zorzano A, Mora S. Hypoxia-induced HIF1alpha activation regulates small extracellular vesicle release in human embryonic kidney cells. Sci Rep. 2022;12(1):1443. · DOI
  158. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009;284(49):34211–22. · DOI
  159. Busco G, Cardone RA, Greco MR, Bellizzi A, Colella M, Antelmi E, et al. NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space. FASEB J. 2010;24(10):3903–15. · DOI
  160. Matboli M, ElGwad AA, Hasanin AH, El-Tawdi A, Habib EK, Elmansy RA, et al. Pantoprazole attenuates tumorigenesis via inhibition of exosomal secretion in a rat model of hepatic precancerous lesion induced by diethylnitrosamine and 2-acetamidofluorene. J Cell Biochem. 2019;120(9):14946–59. · DOI
  161. Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y, et al. Extracellular vesicle-packaged HIF-1alpha-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019;21(4):498–510. · DOI
  162. Yang K, Fan M, Wang X, Xu J, Wang Y, Tu F, et al. Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis. Cell Death Differ. 2022;29(1):133–46. · DOI
  163. Wang JD, Wang YY, Lin SY, Chang CY, Li JR, Huang SW, et al. Exosomal HMGB1 Promoted Cancer Malignancy. Cancers. 2021;13(4):877. · DOI
  164. Panda S, Chatterjee O, Roy L, Chatterjee S. Targeting Ca2+ signaling: A new arsenal against cancer. Drug Discov Today. 2022;27(3):923–34. · DOI
  165. Xia L, Wang X, Yao W, Wang M, Zhu J. Lipopolysaccharide increases exosomes secretion from endothelial progenitor cells by toll-like receptor 4 dependent mechanism. Biol Cell. 2022;114(5):127–37. · DOI
  166. Miao Y, Li G, Zhang X, Xu H, Abraham SN. A TRP Channel Senses Lysosome Neutralization by Pathogens to Trigger Their Expulsion. Cell. 2015;161(6):1306–19. · DOI
  167. Ma X, Chen Z, Hua D, He D, Wang L, Zhang P, et al. Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance. Proc Natl Acad Sci U S A. 2014;111(17):6389–94. · DOI
  168. Didiasova M, Zakrzewicz D, Magdolen V, Nagaraj C, Balint Z, Rohde M, et al. STIM1/ORAI1-mediated Ca2+ Influx Regulates Enolase-1 Exteriorization. J Biol Chem. 2015;290(19):11983–99. · DOI
  169. Kim OK, Nam DE, Hahn YS. The Pannexin 1/Purinergic Receptor P2X4 Pathway Controls the Secretion of MicroRNA-Containing Exosomes by HCV-Infected Hepatocytes. Hepatology. 2021;74(6):3409–26. · DOI
  170. Tawfik B, Martins JS, Houy S, Imig C, Pinheiro PS, Wojcik SM, et al. Synaptotagmin-7 places dense-core vesicles at the cell membrane to promote Munc13–2- and Ca2+-dependent priming. Elife. 2021;10:e64527. · DOI
  171. Skowyra ML, Schlesinger PH, Naismith TV, Hanson PI. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science. 2018;360(6384):eaar5078. · DOI · Paper page
  172. Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, et al. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Molecular & cellular proteomics : MCP. 2013;12(2):343–55. · DOI
  173. Le Bras M, Gorelick N, Pautet S, Tyler B, Manenti S, Skuli N, et al. Translational Regulation by hnRNP H/F Is Essential for the Proliferation and Survival of Glioblastoma. Cancers. 2022;14(5):1283. · DOI
  174. Guan L, Wu B, Li T, Beer LA, Sharma G, Li M, et al. HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors. Nat Commun. 2022;13(1):4078. · DOI
  175. McKenzie AJ, Hoshino D, Hong NH, Cha DJ, Franklin JL, Coffey RJ, et al. KRAS-MEK Signaling Controls Ago2 Sorting into Exosomes. Cell Rep. 2016;15(5):978–87. · DOI
  176. Wang F, Oudaert I, Tu C, Maes A, Van der Vreken A, Vlummens P, et al. System Xc- inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance. Cancer Lett. 2022;535:215649. · DOI
  177. Fan M, Sun W, Gu X, Lu S, Shen Q, Liu X, et al. The critical role of STAT3 in biogenesis of tumor-derived exosomes with potency of inducing cancer cachexia in vitro and in vivo. Oncogene. 2022; 41(7):1050–62. · DOI
  178. Verweij FJ, Bebelman MP, Jimenez CR, Garcia-Vallejo JJ, Janssen H, Neefjes J, et al. Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling. J Cell Biol. 2018;217(3):1129–42. · DOI
  179. Im EJ, Lee CH, Moon PG, Rangaswamy GG, Lee B, Lee JM, et al. Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A. Nat Commun. 2019;10(1):1387. · DOI
  180. Novo D, Heath N, Mitchell L, Caligiuri G, MacFarlane A, Reijmer D, et al. Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels. Nat Commun. 2018;9(1):5069. · DOI
  181. Cooks T, Pateras IS, Jenkins LM, Patel KM, Robles AI, Morris J, et al. Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246. Nat Commun. 2018;9(1):771. · DOI
  182. Yu X, Riley T, Levine AJ. The regulation of the endosomal compartment by p53 the tumor suppressor gene. FEBS J. 2009;276(8):2201–12. · DOI
  183. Mitani F, Lin J, Sakamoto T, Uehara R, Hikita T, Yoshida T, et al. Asteltoxin inhibits extracellular vesicle production through AMPK/mTOR-mediated activation of lysosome function. Sci Rep. 2022;12(1):6674. · DOI
  184. Zou W, Lai M, Zhang Y, Zheng L, Xing Z, Li T, et al. Exosome Release Is Regulated by mTORC1. Adv Sci (Weinh). 2019;6(3):1801313. · DOI
  185. Wei Y, Tang X, Ren Y, Yang Y, Song F, Fu J, et al. An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity. Signal Transduct Target Ther. 2021;6(1):421. · DOI
  186. Sparn C, Dimou E, Meyer A, Saleppico R, Wegehingel S, Gerstner M, et al. Glypican-1 drives unconventional secretion of fibroblast growth factor 2. eLife. 2022;11:e75545. · DOI
  187. Javidi-Sharifi N, Martinez J, English I, Joshi SK, Scopim-Ribeiro R, Viola SK, et al. FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells. Elife. 2019;8:e40033. · DOI
  188. Ruiz-Martinez M, Navarro A, Marrades RM, Viñolas N, Santasusagna S, Muñoz C, et al. YKT6 expression, exosome release, and survival in non-small cell lung cancer. Oncotarget. 2016;7(32):51515–24. · DOI
  189. Liu YD, Zhuang XP, Cai DL, Cao C, Gu QS, Liu XN, et al. Let-7a regulates EV secretion and mitochondrial oxidative phosphorylation by targeting SNAP23 in colorectal cancer. J Exp Clin Cancer Res. 2021;40(1):31. · DOI
  190. Urabe F, Kosaka N, Sawa Y, Yamamoto Y, Ito K, Yamamoto T, et al. miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1. Science advances. 2020;6(18):eaay 3051. · DOI
  191. Wang FW, Cao CH, Han K, Zhao YX, Cai MY, Xiang ZC, et al. APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production. J Clin Invest. 2019;129(2):727–43. · DOI
  192. Sun C, Wang P, Dong W, Liu H, Sun J, Zhao L. LncRNA PVT1 promotes exosome secretion through YKT6, RAB7, and VAMP3 in pancreatic cancer. Aging. 2020;12(11):10427–40. · DOI
  193. Tan Z, Cao L, Wu Y, Wang B, Song Z, Yang J, et al. Bisecting GlcNAc modification diminishes the pro-metastatic functions of small extracellular vesicles from breast cancer cells. J Extracell Vesicles. 2020;10(1):e12005. · DOI
  194. Villarroya-Beltri C, Gutiérrez-Vázquez C, Sánchez-Cabo F, Pérez-Hernández D, Vázquez J, Martin-Cofreces N, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980. · DOI · Paper page
  195. Giovannone AJ, Reales E, Bhattaram P, Fraile-Ramos A, Weimbs T. Monoubiquitination of syntaxin 3 leads to retrieval from the basolateral plasma membrane and facilitates cargo recruitment to exosomes. Mol Biol Cell. 2017;28(21):2843–53. · DOI
  196. Flemming JP, Hill BL, Haque MW, Raad J, Bonder CS, Harshyne LA, et al. miRNA- and cytokine-associated extracellular vesicles mediate squamous cell carcinomas. J Extracell Vesicles. 2020;9(1):1790159. · DOI
  197. Wang G, Xie L, Li B, Sang W, Yan J, Li J, et al. A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis. Nat Commun. 2021;12(1):5733. · DOI
  198. Xu X, Liu Y, Li Y, Chen H, Zhang Y, Liu J, et al. Selective exosome exclusion of miR-375 by glioma cells promotes glioma progression by activating the CTGF-EGFR pathway. J Exp Clin Cancer Res. 2021;40(1):16. · DOI
  199. Leblanc R, Kashyap R, Barral K, Egea-Jimenez AL, Kovalskyy D, Feracci M, et al. Pharmacological inhibition of syntenin PDZ2 domain impairs breast cancer cell activities and exosome loading with syndecan and EpCAM cargo. J Extracell Vesicles. 2020;10(2):e12039. · DOI
  200. Borel M, Lollo G, Magne D, Buchet R, Brizuela L, Mebarek S. Prostate cancer-derived exosomes promote osteoblast differentiation and activity through phospholipase D2. Biochim Biophys Acta Mol Basis Dis. 2020;1866(12):165919. · DOI

200 of 236 shown

Cited by

Sorted by citations

Metadata

Authors
Han, Q.-F., Li, W.-J., Hu, K.-S., Gao, J., Zhai, W.-L., Yang, J.-H., & Zhang, S.-J.
Venue
Molecular Cancer
Publisher
Springer Science and Business Media LLC
Published
2022-11-01
Volume
21
Issue
1
ISSN
1476-4598
DOI
10.1186/s12943-022-01671-0
PMC
PMC9623991
Cited by
678
References
8
Language
en
Licence
Funders
  • the Key R & D and promotion in Henan Province (212102310114)
  • National Natural Science Foundation of China (82103282, 8217067053)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review